Former Dunfermline, Leeds United and Hibs defender Sol Bamba has been diagnosed with Non-Hodgkin lymphoma.

The experienced defender, currently with Cardiff City, became a well-loved figure at both the Pars and Easter Road during the early stages of his career. An impressive spell down south has followed with the Bluebirds, Leicester City and Leeds United alongside stints abroad.

Hibernian v Celtic: Scottish Premier League

Bamba has received the sad medical diagnosis from doctors. (Photo by Jeff J Mitchell/Getty Images)

But sad news has now been confirmed, Bamba receiving his Non-Hodgkin lymphoma diagnosis, with chemotherapy treatment set to start. A Cardiff City statement reads: “We are saddened to inform supporters that Sol Bamba has been diagnosed with Non-Hodgkin lymphoma.⁣

“With the close support of the Club’s medical team, Sol has immediately started a course of chemotherapy treatment.⁣ Universally admired by teammates, staff and supporters in the Welsh capital, Sol has begun his battle in typically positive spirits and will continue to be an integral part of the Bluebirds family.


“During treatment, Sol will support his teammates at matches and our younger players within the Academy, with whom he will continue his coaching development.⁣”

Cardiff City v Birmingham City - Sky Bet Championship

CARDIFF, WALES – DECEMBER 16: Sol Bamba during the Sky Bet Championship match between Cardiff City and Birmingham City at Cardiff City Stadium on December 16, 2020 in Cardiff, Wales. (Photo by Cardiff City FC/Getty Images)

Hibs paid tribute, saying: “Sending all our love and support to Sol Bamba,” Dunfermline adding: “Everyone at Dunfermline Athletic is behind you, Sol Bamba.”

Leeds United, among various supporters of many clubs and former teammates, said: “The thoughts and best wishes of everyone at Leeds United are with Sol Bamba. Get well soon, the Leeds family is right behind you!”

NTOF now offers a YouTube channel featuring exclusive interviews, post-match discussion, in-depth debate, and much more – LIKE and SUBSCRIBE and don’t miss any of our videos.

Have something to tell us about this article?